Seeking Alpha

ajbrzoz

ajbrzoz
Send Message
View ajbrzoz's StockTalks BY TICKER:
  • ajbrzoz
    $AMRN great buying opportunity. Catalysts: Rx growth; Combo Data in June; NCE still on the table; ANCHOR PDUFA getting closer every day.
    5/19/13
    Reply
      • ajbrzoz
        $AMRN key to anticipated yes to NCE is Vascepa being a prodrug,see pg 19, 1st full paragraph: http://1.usa.gov/ZREP5j
        5/19/13
        Reply
          • ajbrzoz
            AMRN looking solid today and the past few days. Combo data will be out by end of June, per AMRN CEO.
            5/16/13
            Reply
              • ajbrzoz
                $AMRN 14 patents in FDA Orange Book, more on the way. Combo data to be released by end of June, per CEO.
                5/16/13
                Reply
                  • ajbrzoz
                    AMRN since when is a 6% gain in 1-week in any business considered weak?
                    5/14/13
                    Reply
                      • ajbrzoz
                        $AMRN Bulls taking another shot at Amarin. http://yhoo.it/VPKIJZ
                        2/11/13
                        Reply
                          • ajbrzoz
                            $AMRN Congrats AMRN on the official launch of Vascepa!
                            1/28/13
                            Reply (8)
                          • View all 8 replies
                            • foldholder: when would the sales numbers arrive?
                              2/2/13
                            • nsahbti: Usually the accurate numbers come in through IMS about two to three months after launch. Early indicators will be from physician statements
                              2/4/13
                              • ajbrzoz
                                $AMRN USPTO Notification of Allowance for ANCHOR Patent for App 12/815,569 to be mailed on 01/25/13.
                                1/23/13
                                Reply
                                  • ajbrzoz
                                    AMRN will be at 80-100+ pps in 3 yrs. if BO hasn't happened by then.
                                    12/8/12
                                    Reply
                                      • ajbrzoz
                                        AMRN Amarin takeover or strategic collaboration still probable, says Leerink. http://bit.ly/RH7zdU
                                        12/7/12
                                        Reply
                                          • ajbrzoz
                                            AMRN "Despite Recent Opinion Pieces To The Contrary, Omega-3 Fish Oil Market Continues to Heat Up" http://yhoo.it/UT4v9Q
                                            11/21/12
                                            Reply (1)
                                            • jowl: aj - thanks for the post. Still long. All this NCE talk keeps stock depressed. Have to believe better days are ahead.
                                              11/21/12
                                              • ajbrzoz
                                                AMRN: too much concern about NCE status, when the patents keep rolling in. Be patient, folks. Great things are going to happen.
                                                11/17/12
                                                Reply (3)
                                              • View all 3 replies
                                                • crt6978: $AMRN The ppl who know,just want an answer y/n so we can get on with it, may get buyout w/2 pps,w&w/o NCE, euther way longs win.28+ or 32+
                                                  11/18/12
                                                • nsahbti: TEVA is looking for a leverage in cardio, good to have them in the bidding. NCE does not matter, only for negotiation purposes. Patience...
                                                  11/19/12
                                                  • ajbrzoz
                                                    AMRN Issue date for Patent App. 12/769,885 is 10/30/12. Patent # is 8298554. Confirmed on USPTO public PAIR.
                                                    10/26/12
                                                    Reply (1)
                                                    • tothman: $AMRN I seem to be the only other one who cares about this. It's a key composition patent and prob the most important disclosure thus far.
                                                      10/26/12
                                                      • ajbrzoz
                                                        Short positions in AMRN declining: http://on.wsj.com/TzGjyk
                                                        10/24/12
                                                        Reply
                                                          • ajbrzoz
                                                            AMRN AZ buyout speculation article: http://bit.ly/RTHEed
                                                            10/23/12
                                                            Reply
                                                              • ajbrzoz
                                                                AMRN buyout rumor by AZ starting to circulate.
                                                                10/23/12
                                                                Reply (1)
                                                                • iadops40: AZN
                                                                  10/24/12
                                                                  • ajbrzoz
                                                                    AMRN New Vascepa patents added to FDA Orange Book: http://1.usa.gov/NMF2zQ
                                                                    10/23/12
                                                                    Reply
                                                                      • ajbrzoz
                                                                        AMRN Patent #8793727 will be issued on 10/23/12 for patent application 12/702889. Go to USPTO public PAIR.
                                                                        10/4/12
                                                                        Reply
                                                                          • ajbrzoz
                                                                            MRIC.OB MRI Interventions & Brainlab Launch European Commercialization Effort. http://yhoo.it/PHneDE
                                                                            9/19/12
                                                                            Reply
                                                                              • ajbrzoz
                                                                                AMRN. PropThink: New Opportunity To Buy Amarin; NCE Issue and JAMA Article Just Speedbumps. http://yhoo.it/Noirdr
                                                                                9/12/12
                                                                                Reply (2)
                                                                                • sector: Added small portion @12.90, wish it would drop more.
                                                                                  9/12/12
                                                                                • wecap: I think it will drop, bearish chart pattern
                                                                                  9/12/12